IP Library Granted Patent US 11,957,504
Granted Patent B2
US 11,957,504 · App. 17/328,928 · Granted Apr 16, 2024

Patient monitoring and treatment systems and methods

Inventors: Clinton T. Siedenburg (Everett, WA); Arthur T. Lounsbery (Woodinville, WA); Mitchell A. Smith (Sammamish, WA); Robert G. Walker (Seattle, WA)
Assignee: Stryker Corporation
A61B8/04A61B5/0022A61B5/0059A61B5/0064A61B5/02028A61B5/0205A61B5/02108A61B5/14551A61B5/349A61B5/6833A61B8/4236A61B8/5223A61H31/005A61B5/02007A61B5/02125A61B5/0245A61B5/029A61B5/0531A61B5/08A61B5/0836A61B5/14552A61B8/06A61B8/4416A61B8/488A61B2560/0214A61B2560/0252A61B2562/242A61H2201/165A61H2201/168A61H2201/5043A61H2201/5058A61H2201/5082A61H2201/5084A61H2201/5097A61H2230/045A61H2230/208A61H2230/255A61H2230/405
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,957,504
App. No.
17/328,928
Granted
Apr 16, 2024
Kind
B2
Abstract

Non-invasive blood pressure (NIBP) systems and methods are disclosed that measure a blood pressure, and in some examples a beat-to-beat blood pressure, of a patient without restricting blood flow. The NIBP systems determine an efficacy of administered cardiopulmonary resuscitation (CPR) to the patient based on the measured blood pressure and are able to optionally output the CPR efficacy or generate user prompts based on the CPR efficacy. Further, the disclosed NIBP systems can generate user instructions to administer further treatment to the patient based on the CPR efficacy.

Claims (65)

1. A medical device, comprising:

an emitter configured to emit a signal toward a blood vessel of a patient, the signal comprising electromagnetic waves or mechanical waves;

a detector configured to receive a reflection of the signal from the blood vessel or blood flowing through the blood vessel; and

a processor configured to:

determine a metric by analyzing the reflection;

determine, by analyzing an electrocardiogram (ECG) of the patient and the metric, whether the patient has pulseless electrical activity (PEA);

output an indication of whether the patient has PEA;

determine, by analyzing the reflection, a geometry of the blood vessel;

determine a severity score indicating a severity of a condition of the patient by analyzing the geometry of the blood vessel and a velocity of the blood flowing through the blood vessel; and

output the severity score.

2. The medical device of claim 1 , wherein the signal comprises ultrasound or light.

3. The medical device of claim 1 , wherein the metric comprises a blood pressure of the patient.

4. The medical device of claim 1 , wherein the processor is configured to determine a metric by analyzing the reflection by:

determining a pulse wave velocity of the blood vessel;

determining a blood velocity of the blood flowing through the blood vessel; and

determining a product of the pulse wave velocity, the blood velocity, and a density of the blood, the metric being equal to the product,

wherein the pulse wave velocity or the blood velocity is determined by analyzing the reflection.

5. The medical device of claim 1 , wherein the processor is further configured to:

determine, by analyzing the reflection, the velocity of the blood flowing through the blood vessel; and

identify the condition of the patient by analyzing the geometry of the blood vessel or the velocity of the blood flowing through the blood vessel.

6. The medical device of claim 5 , wherein the condition of the patient comprises an aneurysm, a return of spontaneous circulation (ROSC), or a vascular blockage.

7. The medical device of claim 1 , wherein the blood vessel is located in a neck or in an abdomen of the patient.

8. A method, comprising:

emitting a signal toward a blood vessel of a patient, the signal comprising electromagnetic waves or mechanical waves;

detecting a reflection of the signal from the blood vessel or blood flowing through the blood vessel;

determining a metric by analyzing the reflection;

determining, by analyzing an electrocardiogram (ECG) of the patient and the metric, whether the patient has pulseless electrical activity (PEA); and

outputting an indication of whether the patient has PEA,

wherein determining the metric by analyzing the reflection comprises:

determining a pulse wave velocity of the blood vessel, and

determining an instantaneous blood velocity of the blood flowing through the blood vessel, wherein the pulse wave velocity and the instantaneous blood velocity are determined simultaneously.

9. The method of claim 8 , wherein the signal comprises ultrasound or light.

10. The method of claim 8 , wherein the metric comprises a blood pressure of the patient.

11. The method of claim 8 , wherein determining the metric by analyzing the reflection further comprises:

determining a product of the pulse wave velocity, the instantaneous blood velocity, and a density of the blood, the metric being equal to the product,

wherein the pulse wave velocity or the instantaneous blood velocity is determined based on the reflection.

12. The method of claim 8 , further comprising:

determining, by analyzing the reflection, a geometry of the blood vessel or a velocity of the blood flowing through the blood vessel; and

identifying a condition of the patient by analyzing the geometry of the blood vessel or the velocity of the blood flowing through the blood vessel.

13. The method of claim 11 , further comprising:

determining, by analyzing a geometry of the blood vessel or the velocity of the blood flowing through the blood vessel, a severity score indicating a severity of a condition of the patient; and

outputting the severity score.

14. The method of claim 11 , wherein a condition of the patient comprises an aneurysm, a return of spontaneous circulation (ROSC), or a vascular blockage.

15. The method of claim 8 , wherein the blood vessel is located in a neck or in an abdomen of the patient.

16. The medical device of claim 1 , further comprising:

a sensor configured to detect the ECG of the patient,

wherein:

the signal comprises an ultrasound signal,

determining the metric based on the reflection comprises:

determining a pulse wave velocity by analyzing the reflection of the ultrasound signal from the blood vessel;

determining a velocity of the blood flowing through the blood vessel by analyzing the reflection of the ultrasound signal from the blood flowing through the blood vessel; and

determining a blood pressure of the patient as a function of the pulse wave velocity and the velocity of the blood flowing through the blood vessel, and

determining whether the patient has PEA further comprises analyzing the blood pressure.

17. The medical device of claim 1 , wherein the condition of the patient comprises an aneurysm, a return of spontaneous circulation (ROSC), or a vascular blockage.

18. The medical device of claim 16 , wherein the blood vessel is located in a neck or in an abdomen of the patient.

19. A medical device, comprising:

an emitter configured to emit a signal toward a blood vessel of a patient, the signal comprising electromagnetic waves or mechanical waves;

a detector configured to receive a reflection of the signal from the blood vessel or blood flowing through the blood vessel; and

a processor configured to:

determine a metric by analyzing the reflection;

determine, by analyzing an electrocardiogram (ECG) of the patient and the metric, whether the patient has pulseless electrical activity (PEA); and

output an indication of whether the patient has PEA,

wherein determining the metric by analyzing the reflection comprises:

determining a pulse wave velocity of the blood vessel, and

determining an instantaneous blood velocity of the blood flowing through the blood vessel, wherein the pulse wave velocity and the instantaneous blood velocity are determined simultaneously.

Assignments (2)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER CORPORATION
To: STRYKER CORPORATION
Reel/Frame 069737/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2021
From: SIEDENBURG, CLINTON T.; LOUNSBERY, ARTHUR T.; SMITH, MITCHELL A.; WALKER, ROBERT G.
To: STRYKER CORPORATION
Reel/Frame 056334/0586 →